Akari Therapeutics, Plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AKTX Nasdaq 2836 www.akaritx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akari Therapeutics, Plc

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Shares Still Up This Week - Dec 12th, 2025 9:17 am
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - Dec 11th, 2025 9:10 am
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - Dec 10th, 2025 9:08 am
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - Dec 9th, 2025 9:06 am
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer - Dec 9th, 2025 6:40 am
European Equities Traded in the US as ADRs Little Changed in Monday Trading - Dec 8th, 2025 9:01 am
Akari Therapeutics Provides Corporate Update and Highlights its ADC Payload Innovation Expected to Drive Value in New CEO Corner Segment - Dec 4th, 2025 7:00 am
European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - Dec 3rd, 2025 9:29 am
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - Dec 1st, 2025 9:02 am
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gain 4% for Week - Nov 28th, 2025 9:11 am
European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading - Nov 26th, 2025 9:03 am
Akari Therapeutics Announces Release of the Next CEO Corner Segment - Nov 25th, 2025 7:00 am
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - Nov 19th, 2025 9:07 am
European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading - Nov 18th, 2025 9:05 am
Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer - Nov 18th, 2025 6:35 am
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading - Nov 14th, 2025 9:02 am
European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading - Nov 10th, 2025 9:05 am
Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhibitors - Nov 10th, 2025 6:30 am
European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading; Down Modestly for Week - Nov 7th, 2025 9:05 am
European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading - Nov 4th, 2025 9:14 am